Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
International Hemp Exchange, commonly branded as iHEMPx and in more recent seed-focused branding as International Hemp, is a private U.S. hemp company that operates a marketplace and supply-chain business while also supplying industrial hemp seed and genetics. The company was founded in 2016 in Colorado to connect buyers and sellers across the hemp value chain, offering sourcing, consulting, and exchange services for seeds, biomass, flower, and related products. More recently, its public-facing business emphasizes certified industrial hemp seed, especially fiber and grain varieties for North American growers. It appears to be an active commercial agriculture company rather than a life science, biotech, pharma, or healthcare developer, and there is no evidence of a therapeutic drug pipeline or clinical-stage programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International Hemp Exchange.